Drugs / GSK biologicals investigational NTHi Mcat vaccine
GSK biologicals investigational NTHi Mcat vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03201211 | Jun 2017 → Mar 2020 | respiratory system disorder | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK biologicals investigational NTHi Mcat vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03201211 ↗ |
| Modality | Vaccine | “GSK biologicals investigational NTHi Mcat vaccine” NCT03201211 ↗ |
| Route | Intramuscular | “Intramuscular vaccination in the deltoid region of the non-dominant arm” NCT03201211 ↗ |